As countries around the globe work to slow the spread of the novel coronavirus, researchers and practitioners from every discipline at the University of North Carolina Gillings School of Global Public Health are turning their expertise into action to support the pandemic response.
Five clinical trials are evaluating the efficacy and safety of remdesivir, which was identified by the World Health Organization as the most promising agent to treat COVID-19. Drs. Danyu Lin and Donglin Zeng in the Department of Biostatistics proposed the use of a common endpoint for all remdesivir trials, which would allow researchers to evaluate the efficacy of treatments by a common criterion.
Dr. Ralph Baric and others in his lab are racing to find answers to COVID-19. Dr. Baric also is working with the Vaccine Research Center at the National Institutes of Health to evaluate lead candidate vaccines.
Dr. Liz Chen and Ms. Hannah Prentice-Dunn are co-leading a task force to explore solutions to the emergency childcare needs of health care workers in the UNC health care system.
Dr. Marisa Domino is working with a team at the North Carolina Division of Health Benefits to examine the use of Medicaid’s emergency provisions and monitor the impact of policies like transitioning office visits to telemedicine.
The Carolina Global Breastfeeding Institute is providing implementation support and guidance for recommended infant feeding practices in the context of COVID-19.
The N.C. Institute for Public Health (NCIPH) is providing consultation and technical assistance to local and state public health agencies across the state.
No Kid Hungry N.C. — an initiative based in the UNC Center for Health Promotion and Disease Prevention — has been very active in providing food to children during school closures.Friday Letter Submission, Publish on March 20